Cumberlege Report Debate
Full Debate: Read Full DebateMike Penning
Main Page: Mike Penning (Conservative - Hemel Hempstead)Department Debates - View all Mike Penning's debates with the Department of Health and Social Care
(2 years, 6 months ago)
Westminster HallWestminster Hall is an alternative Chamber for MPs to hold debates, named after the adjoining Westminster Hall.
Each debate is chaired by an MP from the Panel of Chairs, rather than the Speaker or Deputy Speaker. A Government Minister will give the final speech, and no votes may be called on the debate topic.
This information is provided by Parallel Parliament and does not comprise part of the offical record
I beg to move,
That this House has considered the Cumberlege Report.
It is a pleasure to serve under your chairmanship, Mr Rosindell. I have secured a debate about fulfilling the recommendations of the Cumberlege report because I do not feel that we are making enough progress. We had a debate on the Floor of the House in July and a written ministerial statement on 21 July. To stay in order, Mr Rosindell, I will only say that the Minister’s answer to the debate and the written ministerial statement were disappointing, in many ways. In my opening remarks, I will seek to address why I believe that to be the case and, fundamentally, ask for certain updates. We are talking about people whose lives have been destroyed. Many hon. and right hon. Members will bring their own examples about various parts of the report, whether they are about Primodos, sodium valproate or mesh, but I will focus my comments on mesh.
I will not spend too much time going over the examples I gave during the debate in July, which can be looked up in Hansard, but I will say that people were given an operation that many did not need, which many were convinced that they should have. Some people did not even know it had happened to them. It took many years for the problems that arose to become apparent, and so those people have effectively been dismissed.
Like many Members, I have constituents who have had their lives stopped, especially women, although I will mention how the issue affects men as well. One constituent, who I have mentioned before, was a physiotherapist in her 40s who had had a child. She had mild incontinence after giving birth and was told to have the mesh implant, which she went ahead and did. Her entire life has been destroyed by that. Trying to remove it was described to her as being like “trying to take hair out of chewing gum”. We should consider that image when we think about the difficulty of the operation. We must not forget that the NHS did this, and the NHS has a responsibility to deal with it. I will make that point several times.
I have been contacted by a lady who is a constituent of my hon. Friend the Member for Thornbury and Yate (Luke Hall). Her name is Paula Goss and both she and he have given me permission to talk about her case. She set up Rectopexy Mesh Victims and Support in March 2019 after she was unable to find much research or information about the meshes that she had had put in. The group now has over 1,100 members, as well as members who have sacrocolpopexy vaginal mesh and hernia mesh. She is the ambassador and advocate for rectopexy and hernia mesh on the Mesh UK Charitable Trust, which has a further 2,000 members.
She had rectopexy mesh in 2014 as she was unable to clear her bowels. She was ill-informed by the now dismissed surgeon, who, as she found out from her notes, inserted three meshes—in the bowel, vagina and posterior. She says:
“All mesh types don’t necessarily show complications straightaway. My Pre mesh insertion issues started again around 9 months after the op, in which I was passed from pillar to post by all medical professionals saying my issues were the menopause or in my head. This went on from 2015 until September 2018 when I was admitted to hospital with a blocked bowel and bladder and had to have enemas and catheters, still they would not connect this to the mesh, upon doing a CT scan at this time they also found a large ovarian tumour, it was then discussed by my gynae oncologist at the BRI and Southmead NBT to do a joint op to remove the tumour and the mesh, due to the incompetence and lack of mesh removal experience at Southmead I ended up having the ovarian tumour removal in January 2019. Thankfully, after testing it was a large benign fibroma, following up with Southmead they then stated that they wouldn’t remove my mesh but would do an op to give me a permanent stoma—again, brushed aside and fobbed off, I sought a second opinion in London privately, whilst we are by no means rich, you can’t put a price on your health...I had to pay £32,000 for my removal, it took over 10 hours and they could not get all of it…two protacks in particular sit very close to the bifurcation of the inferior vena cava on the left and the common iliac on the right. Pre mesh removal I was found to have a heart murmur and I suffered pericarditis quite a few times. My histology on my meshes showed that I was not a candidate for polypropylene and should not have this inserted again…When I discovered I had hernias again I was neglected by the local hospital who at first refused to do a scan, saying I must have an ulcer. it was thanks to my private mesh removal surgeon who contacted my GP and insisted that I was referred for a CT which then clearly showed two large incisional hernias.
The consultant at Southmead stated he would only fix my hernias with polypropylene mesh. After I told him that I couldn’t have that, there was no option but to again look down the private route. Thankfully, my colorectal mesh removal surgeon was able to do this and a date was set for 6 January 2020. However, my hernia started to strangulate and I was luckily rushed to London by my husband, and had this op done on 28 November 2019. This cost £43,000.
This operation was by far the toughest and took a long time to get over, due to ending up with a seroma and now a hiatus hernia due to the trauma to my abdomen.
My journey has not been, and is still not, plain sailing, but I am one of thousands.
Whilst vaginal mesh gets a lot of coverage, ours does not. Rectopexy affects men, women and children…All three main types of mesh need to be included and talked about—bowel mesh, vaginal mesh…sacrocolpopexy and colporrhaphy vaginal mesh and hernia mesh...One of our rectopexy mesh ladies found out that the surgeon who put mesh in also removed her ovary without consent, she sadly committed suicide due to this event.
One of our rectopexy patients was just 15 when she had her mesh inserted. She’s early 20s now and now suffers complications and doesn’t even know if she will ever be able to have children.
We have other ladies in their 20s and early 30s suffering, who may not be able to have children.
We have many rectopexy bowel men on our sites who feel they have nowhere to go and no one who will listen to them.
This is the same for all hernia mesh victims too.
There are many real victims’ journeys that need to be listened to and taken seriously.”
That is what the report did, and why it was so appreciated by the victims, as they were finally being taken seriously. That is where the report’s value lies. Today, I once again push for it to be implemented in full as far as possible, and for recommendation 3 about redress, recommendation 4 and recommendation 5 to be reconsidered.
Recommendation 1 was for an apology. That apology was received in July 2020, given by the Government, but, as good as it was, their actions depend on whether they can justify what they are doing on recommendation 9. Recommendation 2 is:
“The appointment of a Patient Safety Commissioner who would be an independent public leader with a statutory responsibility. The Commissioner would champion the value of listening to patients and promoting users’ perspectives in seeking improvements to patient safety around the use of medicines and medical devices.”
The Government accept recommendation 2, and I ask the Minister for the latest update on that appointment. On 2 December last year, in the other place, the noble Baroness Cumberlege asked Her Majesty’s Government
“when the process to appoint the Patient Safety Commissioner will commence; and when they expect the Commissioner to be in post.”
In response, the noble Baroness Chisholm of Owlpen said:
“My Lords, we are making good progress towards appointing the first patient safety commissioner for England. We expect the appointment of the postholder by spring 2022.”—[Official Report, House of Lords, 2 December 2021; Vol. 816, c. 1443.]
As I said, I would like an update on where we are in that process.
Recommendation 3 is that:
“A new independent Redress Agency for those harmed by medicines and medical devices should be created based on models operating effectively in other countries. The Redress Agency will administer decisions using a non-adversarial process with determinations based on avoidable harm looking at systemic failings, rather than blaming individuals.”
The Government do not accept recommendation 3. As set out in the Government’s statement,
“We have no current plans for a redress agency…We do not believe it is necessary to create a new agency for redress as it is already possible for the Government and others to provide redress for specific issues where that is considered necessary. Neither do we believe that creating an agency would succeed in making products safer as the report suggests, or that grouping existing redress schemes through a single front door would add value for harmed patients.”—[Official Report, 21 July 2021; Vol. 699, c. 72WS.]
I do not accept that it is already possible to provide redress where necessary, because my inbox, and I am sure those of several right hon. and hon. Members, suggests that that is simply not true. It is too vague and takes too long. When I talk about recommendation five, I will discuss where that issue comes to a head.
I come back to my point, which is that the NHS did this to people. I have said it before and I say it again: the problem is very similar to the thalidomide scandal. Eventually we got justice for thalidomide victims. People are just being fobbed off—I have many examples—and that is exactly what happened with thalidomide. Mr Rosindell, can you imagine living an active life, as we all do, and the NHS recommending something that means that you can no longer take part in what you were doing? Imagine being physically and mentally restricted and unable to fulfil your life’s ambitions. A full quango might not need to be set up, but at the very least we need a ring-fenced department in the NHS to bring those areas together.
Baroness Cumberlege specifically states in her report that her terms of reference prevented her from talking about individual compensation and redress. Is my right hon. Friend suspicious, like me and probably many others, that that was specifically written into the plan so that she could not do what my right hon. Friend is asking for?
That is where we have to dig into recommendation 4:
“Separate schemes should be set up for each intervention—HPTs, valproate and pelvic mesh—to meet the cost of providing additional care and support to those who have experienced avoidable harm and are eligible to claim”.
The Government do not accept recommendation 4. That is exactly the same situation as with thalidomide. One of my earliest campaigns in 2012 was to extend the grant to victims, and my hon. Friend the Member for North Dorset (Simon Hoare) took that campaign further to make it a permanent grant. People will not recover from what happened, whether it was drug-induced or operation-induced.
My constituent who has had mesh removed emailed me only today to say that four years down the line things are better, but they have not improved to the point where she can really live her life. She says she is mentally exhausted and does not want to go on. She had a thriving physiotherapy career that she cannot go back to. She is only in her 40s and has the rest of her life to live. The Government have a responsibility because the Government run the NHS. I interchange the words “NHS” and “Government”, but the NHS is the Government. That is where this situation falls on the Minister:
“While the Government are sympathetic to the experiences of those patients who gave evidence to the report, our priority is to improve the future safety of medicines and medical devices.”—[Official Report, 21 July 2021; Vol. 699, c. 72WS.]
Trying to prevent further catastrophe is obviously very important—that is one thing—but thousands of people will suffer for the rest of their lives thanks to this treatment.
I will draw the distinction between this surgery and breast-enhancement surgery. Many people have had that done privately and then when there have been complications, they have had the operation to sort it out on the NHS. There is often a lot of debate around whether that is right or wrong. That is not where I want to go today. However, if we are willing to do that for things that people have had done privately, why are we not willing to redress the issues of people who have had things done by the NHS?
We are talking about women from their teens all the way up. Some people think the problem is with the elderly end of the population, but we are talking about those in their teens upwards. As I said, we did recognise the situation with thalidomide. I know that costs come into it, but there is a moral responsibility to redress the situation.
It is a pleasure to serve under your chairmanship, Mr Rosindell.
Groundhog day—here we go again. This is almost the identical debate that we had before. If this was in the main Chamber, especially if it was not on a Thursday afternoon, the Chamber would be full, because there is not one constituency that does not have somebody affected by the three conditions. As the hon. Member for Chesham and Amersham (Sarah Green) said just a moment ago, what is the point of commissioning a report or having an inquiry and then ignoring the key components of its conclusions?
I congratulate my right hon. Friend the Member for Elmet and Rothwell (Alec Shelbrooke) on securing the debate. Sadly, I think we will end up having more. I am a loyal member of Her Majesty’s Government. I am absolutely aghast that we are here again discussing this. I thank my right hon. Friend the Member for Maidenhead (Mrs May), our former Prime Minister, for her support. The report would not be here today without her.
I congratulate Baroness Cumberlege, along with Marie Lyon, who ran the fantastic Primodos campaign. There was some worry about the experts that the baroness had around her, and we questioned her on those points to make sure that the inquiry was truly independent. At the start, the all-party parliamentary group was very sceptical because we had been let down by the expert working group. What an oxymoron that is! It is an insult to experts. Those on the group might be experts in their particular field, but they are not experts in people.
I want to talk in particular about Primodos. As several colleagues have said, very vulnerable women went to their GP for help, because they thought that they might be pregnant. They were myriad different ages, from myriad different parts of the country and certainly from different economic backgrounds. This touched everyone. They went to their GP and said, “I think I might be pregnant.” That GP, in an NHS GP’s surgery, pulled open a drawer, gave them some tablets and said, “This will tell you whether you are pregnant”—no advice, no concerns, no documentation.
These days, I have to take some medication and it is like “War and Peace” when I open the packet—even if I buy an aspirin. Although that is understandable, as aspirin can be very dangerous, so I will not use that example—perhaps ibuprofen or something. Clearly, that is because the industry, the pharmas, know that they have to cover themselves because they might be sued.
The side-effects for some of those ladies and their families and loved ones have been so traumatic. Some had miscarriages, some were told to abort the child and some went on to have children with abnormalities that were frightening then and today. The type of disabilities were similar to those of thalidomide, and one might have thought that we would have learned the lesson of thalidomide—tainted blood, as my right hon. Friend the Member for New Forest East (Dr Lewis) alluded to earlier. But no—we have not learned those lessons.
Some people are alive today, but many have passed away. What is the Department waiting for? Is it, as with thalidomide, for these people to die early? That is why the fund for thalidomide ran out—the Department thought there was enough money in the fund, but people lived, because they have character and they survived, so we are about to top up the fund. These people, too, have lived, with unbelievable conditions. We, in Parliament and as a Government, surely should be here for them.
When the initial report of that expert working group was produced, many of us in the Chamber said that it was a complete whitewash. It was indeed a complete whitewash. The all-party parliamentary group had some evidence sessions with members of the working group, and I asked, “Who gave you the authority to change the ministerial guidance on what your report should look like?” They said, “Oh, we just thought that we would change it.” It was all about the evidential base—it was easier for them to come to the conclusions that they wanted to come to.
We said it was a whitewash, and the Government did the right thing: they got Baroness Cumberlege to look at the three areas—I apologise to the other groups, because I completely agree with everything that was said, as I have constituents in the same situations that have been mentioned. But what is the point of saying to these people, “Here’s the report by the baroness, and the Government accept some of it”?
I had the honour of being the Policing Minister when my right hon. Friend the Member for Maidenhead was the Home Secretary. The Hillsborough inquiry report was difficult. Governments of all colours had previously rowed away from the issue, because in general they were probably frightened about the conclusions—the conclusions were frightening. However, we did the right thing and we honoured the report. That is absolutely what should have happened with this report.
The Government, though, are turning around to say to these families that I am talking about today, and to the families involved with the other two conditions: “If you don’t like what we are saying, sue us.” I have been told that we have to be slightly careful not to go too much into the legal side of this, but they have fought all their life to look after their loved ones and to say, “This is not on me.” They were worried about the ladies who took the tablets, but men—the fathers of these children—have been told, “This was probably genetic. That happens.” That does happen, but this happened because NHS doctors gave these tablets to patients in an NHS surgery and did not tell them the risks, even though they knew them. Back in 1967, Primodos was removed because of the risks, yet it was still available in 1978. I had been in the Army for four years in 1978; it was not that long ago. They knew the risks, but they continued.
People ask me why GPs were doing this. It was because drugs company salespeople were going into the GP surgeries and pushing their product at the doctors, promoting it so they could earn more and more money. We need pharmaceutical companies. Many of the medicines that we have today would not have been invented without pharmaceutical companies. However, when they get it wrong, we have to hold them to account. They got it wrong, and the Department of Health got it wrong, and thus Governments—it does not matter what colour they were; I do not care—got it wrong.
We touched earlier on why we are fighting this. I had the honour of serving in six or seven Departments—I lose track sometimes; it was three at one time, I think—and I was told lots of times by my officials that we needed to fight or challenge something. That happened lots of times at the Home Office; my right hon. Friend the Member for Maidenhead is nodding away. I was the Disabilities Minister at the Department for Work and Pensions, and I asked why we were not settling with these people, because we had made a mistake. I was told that the Treasury counsel thought we might have a case, with about a 30% chance of success. Come on, guys.
At the end of the day, Governments are worried about saying, “Excuse me; we got it wrong and we are going to put it right.” The Government are going to put it right, we hope, but mistakes will still happen. That is the nature of medicine, I am afraid. But when we get it wrong, and doctors get it wrong, for once in their lives I wish they would just turn around and put their hands up. That is what I hear from my constituents in the complaints that come through my office; I am sure it is the same for all colleagues in this room. We see these reports and the amount of compensation that is to be paid, and they are challenged, and then eventually people get their money. There is something wrong.
I have sat in the Minister’s chair on more than one occasion and been bombarded, quite rightly at times. However, this is not about the Minister; it is about Government, and the structure of Government. Using the Minister as a conduit, this needs to go further, back up to the top and, at the end of the day, to the Treasury. The reason why people in government are so worried is because this could set a precedent. They are worried about whether it will cost the Treasury lots of money. Let us be honest: it will cost the Treasury lots of money, sometimes in ways that it is not even expecting. We have already talked about PIP and access to work. We could go on about the amount in benefits that this is costing Government anyhow. As well as that, the decent thing to do is to honour recommendation 4 of the Cumberlege report. It does not use the word “compensation” because Baroness Cumberlege was not allowed to use that; the terms of reference given to her were written to make sure that she could not. However, it says that this has been done to these people, we got it wrong, they trusted the Government and the Government have to compensate them.
I will say one final thing. The NHS is a wonderful organisation. Around the world, people look at our NHS and say, “We wish we had that. We wish we could do that.” This is damaging the NHS. This, tainted blood and thalidomide—we could go on about other things—are a danger. We rightly addressed tainted blood and thalidomide, thank goodness; the campaigning by the thalidomide action groups was absolutely phenomenal. This needs to be resolved before it damages the NHS even more. Colleagues will retire or leave. Some people—particularly those affected by Primodos—will pass away. But we will not go away. We will go on and on and on about it in this House until compensation—recommendation 4—is provided to our constituents, and that is the right thing to do.
[Sir Graham Brady in the Chair]
It is a pleasure to serve under your chairmanship, Sir Graham. I pay tribute to the right hon. Member for Elmet and Rothwell (Alec Shelbrooke) for securing this important debate and for his continued campaigning on women’s issues. We have heard today harrowing accounts of women’s experiences. It is really important that we hear those accounts and that they are repeated over and again, because we need to remind ourselves that these are real human beings who have to live with this day in, day out. It is important that we record that in this House.
I thank right hon. and hon. Members for their powerful contributions to the debate. As a fairly new Member—I believe I am the newest Member in the Chamber—and having taken some time off for maternity, I have spent less time here than most Members present, so this is the first time that I am hearing about the progress that has been made on the Cumberlege review. It is really depressing to hear that we have not made much progress on the recommendations.
The pressing thread throughout the debate has been the patronising attitude to women’s voices, as was mentioned by the right hon. Member for Maidenhead (Mrs May), which continues. I take this opportunity to pay tribute to campaigners for their tireless work around the Cumberlege review—particularly the Association for Children Damaged by Hormone Pregnancy Tests, without which the review would have never taken place and we would not be here today.
We have heard that Baroness Cumberlege’s excellent review looked into the use of Primodos, the use of sodium valproate during pregnancy, and the use of pelvic mesh implants. Those medicines and medical devices have caused untold physical, developmental and emotional harm to tens of thousands of women. It is almost four years since the independent medicines and medical devices safety review was announced, but it is over 50 years since these treatments started to be used and, as has just been mentioned, women have been trying to get their voices heard for decades.
The hon. Lady may be new to the House, but she is doing very well in trying to understand the position. In the case of Primodos, that was not a drug that was going to cure anything; it was simply a tablet that told the person who took it whether they were pregnant. There were other methodologies around at the time that were deemed to be safe, but GPs continued to give out Primodos when they knew it was not safe. It is quite a clear, difficult thing: GPs were giving out a drug years after the relevant bodies said it should not be given.
I totally agree with the right hon. Gentleman. I am the mother of an eight-month-old, and during my pregnancy I trusted my GPs and everything they said. I was vulnerable, like all mothers, and I believed that they wanted the best for me. It is absolutely devastating that GPs knew the impact of these drugs yet continued to give them out to women. I thank the right hon. Gentleman for that contribution.
I have constituents in Enfield North who were impacted on by these medicines. My constituent Chris was given Primodos in June 1970 to find out whether she was pregnant. Her daughter Emma is now 51 years old and has suffered throughout her life from limb deformation, spinal problems, scoliosis, joint problems and mental health problems. She lives in chronic and intense pain that does not go away, and she can no longer work full time.
The review set out nine ways in which the Government could have delivered justice, made the lives of those affected—such as Chris and Emma—a little easier, and tried to prevent future incidents. Given the shocking accounts that we have heard today—accounts that the Government have been hearing for years—and the evidence in the review, one would have expected the recommendations to be accepted in full, but that is not the case. As we have heard, the Government have accepted four recommendations, but there are two that they have not accepted. They have accepted two other recommendations in part, and one in principle.
I am pleased that there has been an apology and that there is legislation for a patient safety commissioner. I am pleased that there are specialist centres for the care of those with complications from mesh implants, although I hope the Minister will address the serious concerns we have heard about that. I am also pleased about the changes to how doctors’ conflicts of interest are reported.
However, that is not why we are here today. Implementing those recommendations alone is not good enough. The Government have refused to establish a redress agency for those harmed by such medicines and medical devices, or to set up a separate scheme to meet the costs of providing additional care and support to those who have experienced avoidable harm, which would make a huge difference to families in meeting their exceptionally challenging needs every day. My constituent Emma worries about her ability to keep working and her financial stability. If a scheme were available to support her financially, she would not have to worry.
The Government claim to care about women’s health and making a change. Their vision for women’s health, announced in December, is
“to improve the way in which the health and care system listens to women, and to reset our approach to women’s health by placing women’s voices at the centre of this work.”
They then directly cited Baroness Cumberlege’s review, stating:
“Independent reports and inquiries—not least the report of the Independent Medicines and Medical Devices Safety Review…have found that it is often women whom the healthcare system fails to keep safe and to whom the system fails to listen.”
The Government accept the review and use it, but will not deliver on it. They will not truly listen to those who have been campaigning for justice for years and do right by the families. They will not take the opportunity to reset their approach to women’s health and place women’s voices at the centre of their work by implementing all the recommendations.
In November, I wrote to the Secretary of State for Health and Social Care to ask him to consider establishing a taskforce to implement all the recommendations of the review to put these injustices right. I am still waiting for a response. How can the Government claim that they are taking the review and women’s health seriously if they cannot even respond to a letter from a Member?
Will the Minister please commit to implementing the remaining recommendations? If not, will she explain how not implementing the full recommendations of the Cumberlege review changes anything, or helps to create a system that keeps women safe and listens to them? It is time for her to stand up for the families affected by Primodos, sodium valproate and surgical mesh, and for the Government to stand by their vision by implementing the recommendations in full. Otherwise, we will fail these families and these women again and again.
Yes, absolutely. Part of the consultation we will announce shortly will look at international comparisons. One concern we have about some of the no-fault schemes is the caps on the amount of compensation that can be given. I think some countries have a £1 million cap. I am not an expert on how much compensation these ladies should be due, but we want to make sure that, if we set up systems like that—we are not closed to those ideas—they actually address the issues that these specific women face. We will look at those options in the round.
May I press the Minister and draw her back to the Cumberlege report? What she is talking about going forward sounds really good, and the proof will be in the pudding, as my grandmother would have said. But recommendation 4 of Baroness Cumberlege’s report for the Government talks about—this is my word—compensation. That is so important because, as we heard, some of these people have been caring for their loved ones for the last 50 years. They are not going to be here forever, and they feel enormously vulnerable that their loved ones, who they have looked after for all that time, will be left without their needs being met.
This is not all about the ladies who, for instance, took Primodos tablets. It is about the outcomes—in order words, their children, who are living with this today. We quite rightly concentrate when talking about sodium valproate, mesh and Primodos on what happened at the time, but the consequences of that are these people who are now in their mid-50s and 60s. What will happen to them? They will fall back on the state for PIP and other benefits when actually, recommendation 4 says in black and white that the Government should have sorted it out.
I thank my right hon. Friend for making that point. Compensation can be claimed now. Our concern about setting up a specific body to oversee that is that that would not address the fundamental problem of why it is difficult to get compensation. However, it is a fundamental right of anyone who believes they suffered from clinical negligence to seek compensation, and we actively encourage that.
If the hon. Lady writes to me about that specific case, I am happy to look at it.
The Government published their response to the review in July last year and accepted the majority of the recommendations for improvement. I want to update Members on those because we are absolutely committed to making rapid progress in all the areas in our response. We have committed to publishing an update on the progress of all the recommendations that we accepted, and we aim to publish that in the summer. If colleagues want to hold my feet to the fire, they will certainly get a formal update in the summer.
We have made strong progress on some of the changes.
It is fortunate that we have so much time because we can ask lots of questions. Marie Lyon, the Primodos campaigner, has effectively been told by the Minister’s predecessor, “See you in court”. I do not know about the experiences of the other conditions, but the Primodos campaigners do not have money. They have the will, but they are completely exhausted. They pinned all their hopes on the Government accepting the report’s recommendations. These people will not get a no win, no fee arrangement or a pro bono. They will have to try to fundraise, and they will, but is that morally right when the baroness’s report and its recommendations, published by the Government, say that they should not have to go through that?
Specifically on Primodos, there is pending litigation so it is difficult for me to comment while that is in progress, but, depending on the outcome, the Government will respond to that.
That is why we introduced NHS Resolution to facilitate a quicker method of getting compensation to those who have been harmed through clinical negligence. I encourage hon. Members to look at the work of NHS Resolution. We are doing more to ensure a better experience for patients, but we are fundamentally committed to ensuring that those who have been harmed get the support they need.
The Primodos victims—I am not allowed to talk about the court case—have had no choice. They are in court now because the Government would not take on Cumberlege recommendation 4. It is all well and good talking about what will happen in the future, but they are living with this now. They are in court today. Surely the Government should settle with them now. Like the Minister has said several times, these things get settled out of court. Well, settle with Primodos victims now and they will not have to go through that.
I cannot speak on active litigation claims, but between 70% to 80% of claims are settled out of court because that is the avenue we want to go down. It is not in anyone’s interest to go to court. I am happy to keep hon. Members updated. There will be a formal review in the summer, but I am happy to have my feet held to the fire to ensure we deliver on the Cumberlege review for those patients who have suffered.